What talking U joyvest , Bintai Generex vaccine is USA product and nothing to do with China Are nuts already joyvest KKK KKS
KaKiKong KaKiSong
tut tut
joyvest Yeap...according to the news,china vaccine is more superior to pfizer and moderna because
no1.china one is easier in terms of logistics as It need to be stored in temperature of 7- 8 c as compared to pfizer and moderna which require extreme high cold temperature
No2.china one is made of the substance which causes lesser side effect
No.3.there are more signs that many countries are more likely to opt for the more acceptable china vaccine...
KUALA LUMPUR (Nov 12): Bintai Kinden Corp Bhd's majority-owned subsidiary Bintai Healthcare Sdn Bhd (BHSB) today signed a memorandum of understanding (MOU) with Australia-listed International Equities Corp Ltd's (IEC) wholly owned subsidiary IEC Properties Pty Ltd under a planned arrangement for which IEC will have the sole distribution rights for a Covid-19 vaccine in Australia and New Zealand.
According to Bintai Kinden's filing with Bursa Malaysia today, the MOU enables BHSB and IEC to further negotiate the terms and conditions wherein IEC will be sub-licensed by BHSB to supply the Ii Key-SARS-CoV-2 vaccine in Australia and New Zealand.
"BHSB intends to collaborate with IEC which has the extensive reach in the said markets by granting IEC the exclusive distribution rights to market, distribute and sell the vaccine in Australia and New Zealand," Bintai Kinden said.
Bintai Kinden said it has partnered US-based Generex Biotechnology Corp to advance the commercialisation of the vaccine in Malaysia.
ADVERTISING
Pursuant to the distribution and licensing agreement entered into among BHSB, Generex and NuGenerex Immuno-Oncology Inc, BHSB has been given the first right of refusal to market and distribute the vaccine in Australia and New Zealand, according to Bintai Kinden.
Some people eye sight long sighted, some short sighted, how far you can see? Some says I can see few hundred km, some says I can see the plane, some says I can see moon, Sun and the evens 356 light years star... Investment to get high return is base on how far you can see... If you want to wait until the P&L right in front of you, then this is what you get today if you are still holding glove stock. If you enter early stage congratulations, if you enter at above RM15 for top glove, I would say 'po zhong'. Don't let your mind limit your sight.
Tawin is said to buy 30% equity shares of RoycePharma,a 15 years old pharmaceutical company and registered holder of MDA's establisment license approved to import and dustribution of medical devices and possibly the Covid vaccine. RoycePharma is likely to have connection of the China Shanghai Fosan Vaccine. Upcoming "vaccine play" counter to bet in.
Vic, please feel free to correct me if I am wrong. TG's Board approved their Bonus issue of 2 for 1 on 20th July, 2020. The price was around RM26.40 per share on 28th July. Thus, their ex-price was at RM8.80 per share and you have 3 lots instead of 1.
This price was further run up to be only 0.20 sens short of being the highest market cap on KLSE, higher than Maybank.
Their price never was at RM15.00 from ex-price and anyone who caught the RM15.00 was most probably pre-Bonus and even at current price of 7.00, with 3 lots, equals RM21.00 from cost price of RM15.00
I think I did my homework and calculations correctly on this. Again, I wish to say I am not holding any Gloves counters.
Trevor, RM15 is my assumption, perhaps few months back.. Before it split... I can quote anything and you can ignore it, but we can't ignore the JPMORGAN article which I posted earlier, glove trend is coming to the end,... Vaccines stocks are rising.. Not only Pfizer and Modenna, all the Vaccines stock will follow the trend...
Vic, those people who bought TG below RM20 are safe. EPF held 6.64% or 534.31 million shares in TG. They had to sell down some from 1st Dec, 2020 and still hold 5.72%. Their buying price was after ex-price from 7.60 to 7.95, from 8.60 to 8.80. Every single RM2.00 drop, they have a paper lost of nearly RM1.0 Billion.
For TG to be at RM3.50? I think many would be willing to put their last ringgit or even pawn their last underwear to buy.
Please go down to the manufacturers and see if you are able to place a Purchase Order for delivery in 2021? All of them, not just TG. Also, check if they are accepting pre-order for 2022, without payment backing?
I don't expect "normal conditions" to be back from the wreckage and damages brought by Covid to be over in the next few months. Not just because some effective vaccine to protect and create herd immunity to bring back normal lives. It still may take years.
No doubt, some play in pharmaceutical stocks is anticipated, BUT please do not mis-construed with so-called "Vaccine" play. Certainly not on KLSE. A Vaccine play belonged to the Pharmaceutical manufacturers, likes of AstraZeneca, Pfizer, J&J, amongst other giants. Is there a Vaccine producer from KLSE? And I don't believe that some "auto mechanics" or "burger stall owners" is able to convince the Government to grant authorisation for them to import, since the Govt itself has warned that they are not dealing through middlemen and the mass immunisation using approved and certified vaccine would be carried out by them.
Again, I wish to state I do not hold any shares from Gloves counters.
Vic, I do not claim to be an expert, neither did I degrade JP. To each their own reasons and deductions to arrive at a conclusion and opinion. From my view, the EPS and PER for some are still intact and reamins for the next 2-3 years.
Another reason TG unable to supply is the recently their factory shut down due to covid spread. Also there are many competitors already started to produce glove, not only in Malaysia but Asia. As glove is not a high technology business, everyone can join in, just a blink of an eyes. For Vaccine business, not everyone can join at anytime. If you had contract in hand like Solution or Bintai. This is different business , you see even now IOIPG wanna involve, also need to queue.
Trevor, I surrounding with people who is doing trade on the glove, how many containers and gred A or B just tell me. I can quote you the price and time of DELIVERY.WITH CE or FDA Not necessary to get from TG.
Victorino Trevor, I surrounding with people who is doing trade on the glove, how many containers and gred A or B just tell me. I can quote you the price and time of DELIVERY.WITH CE or FDA Not necessary to get from TG.
There are always a few persons like mobbs... Don't know what their intentions of keep throwing negative views.. And this is not the 1st time I met... I assume its either you have personal agenda that you have a purpose to get the price down and let the shark buy in. If not keep shitting here for nothing.
Those who got some status in society only have the opportunity to know TSLYW or family members Not the Ah Chee Ah Kow who come here to talk kokok boast lies n mislead investor to buy con n goreng stock for their own benefits
Sooner or later sure kena sambar kilat
Victorino Sorry to tell you Mobbs68, one of the Lim family also I can call at anytime to order glove stocks. What lies..
Mobbs68.. Please go to attend the AGM.. Mr Lim always stand outside the ballroom welcoming the guest, its unlike what you say... He is a friendly person.
The Star today TANGKAK, 13 Dis — Kerajaan bercadang meningkatkan pembelian vaksin COVID-19 agar dapat menampung keperluan imunisasi hingga 70 peratus rakyat berbanding kuantiti asal sebanyak 30 peratus, kata Perdana Menteri Tan Sri Muhyiddin Yassin.
Beliau berkata ini kerana ada negara yang sudah membeli vaksin itu dengan sesetengahnya memperoleh dalam kuantiti yang banyak melebihi jumlah penduduk mereka sendiri.
“Untuk keperluan Malaysia, kita sudah dapat 30 peratus. Saya sudah arahkan Menteri Kesihatan Datuk Seri Dr Adham Baba bersama (Menteri Sains, Teknologi dan Inovasi) Khairy Jamaluddin untuk berunding supaya dapat tambah dari 30 peratus kepada 60 ataupun 70 peratus.
“Ini dinasihatkan oleh Kementerian Kesihatan Malaysia setakat hari ini… kalau dapat ditingkatkan ke jumlah itu maka lebih terjamin rakyat kita daripada virus COVID-19,” katanya ketika berucap pada Majlis Sambutan Deepavali 2020 Dewan Undangan Negeri Gambir, di sini hari ini.
Muhyiddin yang juga Ahli Dewan Undangan Negeri Gambir berkata beliau telah meminta pembekal menghantar vaksin tersebut secepat mungkin dan Malaysia dijangka menerima bekalan pada Mac tahun depan.
“Berkesan tak berkesan, jangan sampai rakyat marah perdana menteri (sebab tidak beli)… orang lain sudah beli, saya pun beli juga… cepat-cepat kita beli.. (vaksin) akan sampai bulan tiga tahun depan,” katanya.
Pada 24 Nov lalu, Malaysia mengumumkan bahawa ia akan mendapatkan bekalan awal sebanyak 12.8 juta dos vaksin COVID-19 daripada syarikat farmaseutikal Pfizer bagi menampung keperluan imunisasi 20 peratus atau 6.4 juta rakyat negara ini secara percuma. Dua hari sebelum itu, Malaysia memeterai perjanjian dengan fasiliti COVAX untuk memperoleh bekalan vaksin tersebut bagi menampung keperluan imunisasi 10 peratus lagi rakyat negara ini.
Sementara itu, perdana menteri mengarahkan agar hospital sementara merawat COVID-19 dibuka semula berikutan peningkatan secara berterusan kes baharu di beberapa negeri seperti Selangor, Wilayah Persekutuan Kuala Lumpur, Negeri Sembilan dan Johor.
“Ini bermakna walaupun langkah yang kerajaan ambil agak berkesan dari satu sudut, kalau dibandingkan dengan negara-negara lain kita belum dapat mengatasinya.
“Kita belum berjaya melandaikan lekuk COVID-19,” katanya, menambah perkara itu dijangka mengambil masa yang lama.
Ahli Parlimen Pagoh itu berkata sejak hari pertama menjadi perdana menteri, beliau belum lagi dapat berehat memandangkan negara masih dalam ancaman.
“Selagi rakyat kita terancam dan diancam dengan penyakit COVID-19, saya tidak akan berehat. Saya akan bekerja… menguruskan COVID-19, menguruskan ekonomi negara,” kata Muhyiddin.
Sementara itu, perdana menteri berkata kerajaan sedang menjalankan satu kajian menyeluruh mengenai peratusan sebenar rakyat yang jatuh ke paras garis kemiskinan akibat COVID-19.
“Sekarang ini paras garis kemiskinan sudah naik kepada RM2,208 per kapita. Bila sudah naik, lebih ramai rakyat kita yang tergolong dalam kumpulan B40 itu, golongan yang agak miskin dan miskin tegar.
“Bila COVID-19 berlaku, ramai orang yang tidak bekerja, tidak boleh berniaga, buka warung pun tak boleh, pendapatan merosot… syarikat tidak ambil lagi pekerja,” katanya.
Tqvm 3932 you have putting in a very good positive news here... What goes around comes around, you throw bad things to others at last you will receive it backs... That's call the law of attraction. We must always be grateful to bintai.. as the company is doing distribution of covid 19 vaccine that can help people. Australia, New Zealand can bring in lots of profits due to currency.
Vaccine makers, including two of the biggest in the world, suffered setbacks in the push to get more Covid-19 shots across the line, tempering a run of positive news. Sanofi and GlaxoSmithKline Plc delayed advanced trials of their experimental Covid-19 shot after it failed to produce a strong enough response in older people, pushing its potential availability to the end of next year. In another blow, trials of a vaccine being developed by CSL Ltd. and the University of Queensland in Australia ran into difficulties. Sanofi and its U.K. partner will begin a new second-phase study with a more concentrated antigen in February after they said the current dosage failed to generate a good immune response in people 50 years and older. Younger adults showed a response similar to patients who have recovered from the disease. The problem arose after two different reagents used to measure vaccine formulations provided inaccurate information about the concentration of antigens, Sanofi said in an emailed statement. The companies notified U.S. officials about the matter. The delay underscores the difficulties and uncertainties companies face in developing shots in record time against a disease that’s already claimed more than 1.5 million lives. It’s also a blow for governments that were counting on supplies from the two vaccine giants amid expectations the world will need multiple inoculations to stop the spread of the pathogen. Australia meanwhile canceled an order for 51 million doses of a Covid shot being developed by CSL and the Australian university. A component of the vaccine comes from the human immunodeficiency virus, and while that posed no risk of infection, some trial participants had false positive tests for HIV.
The announcements temper some of the optimism following positive trial results from Pfizer Inc. and Moderna Inc. Another inoculation from AstraZeneca Plc and the University of Oxford looks promising, too, despite questions about its effectiveness in older adults. The U.K. and Canada have already approved a shot from Pfizer and partner BioNTech SE that employs messenger RNA technology, and the U.S. and Europe may do so soon. China and Russia have already begun administering their own vaccinations. Sanofi fell as much as 3.3% Friday in Paris, while Glaxo was little changed in London.
Muar: Perdana Menteri, Tan Sri Muhyiddin Yassin mengarahkan bekalan vaksin Covid-19 negara yang dijangka tiba Mac ini, disegerakan penghantarannya.
Muhyiddin berkata, langkah itu bagi memastikan kesihatan rakyat terus terjamin di samping memastikan bekalan vaksin Covid-19 negara boleh digunakan segera.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
mobbs68
740 posts
Posted by mobbs68 > 2020-12-12 23:06 | Report Abuse
What talking U joyvest , Bintai Generex vaccine is USA product and nothing to do with China
Are nuts already joyvest KKK KKS
KaKiKong KaKiSong
tut tut
joyvest Yeap...according to the news,china vaccine is more superior to pfizer and moderna because
no1.china one is easier in terms of logistics as It need to be stored in temperature of 7- 8 c as compared to pfizer and moderna which require extreme high cold temperature
No2.china one is made of the substance which causes lesser side effect
No.3.there are more signs that many countries are more likely to opt for the more acceptable china vaccine...